The RTS,S malaria vaccine: Journey from conception to recommendation

Simple item page
dc.contributor.authorEgbewande OM
dc.date.accessioned2022-07-26T11:50:22Z
dc.date.available2022-07-26T11:50:22Z
dc.date.issued2022
dc.descriptionPublic Health in Practice
dc.description.abstractThe RTS,S malaria vaccine was recently recommended for use among children at risk in malaria endemic regions. Although significant efforts have been made to minimise malaria cases, the results of these innovations have not been totally satisfactory due to specific limitations. However, this revolutionary vaccine has a great tendency to put an end to malaria. Being the first vaccine against malaria, this commentary examines its journey from the idealisation and conception to the recommendation by the World Health Organization. The commentary also examines some of the challenges that might affect the execution of the vaccination programme in sub-Saharan Africa and other malaria endemic regions and suggest recommendations to overcome the possible them.
dc.identifier.citation10.1016/j.puhip.2022.100283
dc.identifier.issn2666-5352
dc.identifier.urihttps://nerd.ethesis.ng/handle/123456789/283
dc.language.isoen
dc.subjectRTS
dc.subjectS
dc.subjectMalaria
dc.subjectVaccine
dc.subjectSub-saharan africa
dc.titleThe RTS,S malaria vaccine: Journey from conception to recommendation
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
The-RTS-S-malaria-vaccine--Journey-from-conception-t_2022_Public-Health-in-P.pdf
Size:
274.98 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal Article